Trials / Completed
CompletedNCT04682574
Role of Mega Dose of Vitamin C in Critical COVID-19 Patients
Effects of Mega Dose Vitamin C in Critically Ill COVID-19 Patients: A Randomized Control Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 278 (actual)
- Sponsor
- University of Lahore · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Vitamin C (ascorbic acid) is a water-soluble vitamin having anti-inflammatory, immunomodulatory, anti-oxidative, antithrombotic and antiviral properties. Considering these effects vitamin C should have beneficial impact in patients suffering from sepsis and acute respiratory distress syndrome (ARDS). The current study is designed to assess the beneficial effects of Vitamin C in COVID-19 infected patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vitamin C | mega dose is given to the selected critically ill patients |
Timeline
- Start date
- 2020-11-02
- Primary completion
- 2022-02-28
- Completion
- 2022-03-10
- First posted
- 2020-12-23
- Last updated
- 2022-05-06
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT04682574. Inclusion in this directory is not an endorsement.